*** Tuesday, April 13, 2021 at 11am EDT| 8am PDT | 4pm BST | 5pm CEST *** In this webcast, we will explore best practices for building an effective Clinical Oversight function using a variety of different delivery models. *** On demand available after final airing until Apr. 13, 2022 ***
Clinical oversight contributes to the success of global trials by ensuring the protection of trial participants as well as the integrity of the data collected. Global regulators are increasingly seeking more formal documentation of sponsor oversight activities during inspections.
Sponsors who are not involved in their clinical oversight processes, or who follow informal documentation strategies, run the risk of inspection findings (e.g., FDA-483) that can cause delays, fines, and potentially impact regulatory approvals. When sponsors choose to outsource this critical function, the pros and cons must be carefully considered.
Key Learning Objectives:
In this webcast you will:
Speakers: Nan Croy, Director of Functional Service Solutions, Advanced Clinical
Melissa Mauriber, Vice President, Clinical Operations Quality & Talent Development, Advanced Clinical
Sponsor: Advanced Clinical
Time and Date: Tuesday, April 13, 2021 at 11am EDT| 8am PDT | 4pm BST | 5pm CEST
On demand available after final airing until Apr. 13, 2022